A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia

Yuri Oshima; Hiroyuki Matsuura; Yusuke Sakurai; Kaho Hirai; Eriko Tani; Naoki Yoshimoto; Kenichi Minami; Fumio Yamasaki; Mayu Nishime; Tomonori Hirashima

Respiratory Medicine Case Reports (Jan 2022)

A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia

Yuri Oshima,
Hiroyuki Matsuura,
Yusuke Sakurai,
Kaho Hirai,
Eriko Tani,
Naoki Yoshimoto,
Kenichi Minami,
Fumio Yamasaki,
Mayu Nishime,
Tomonori Hirashima

Affiliations

Yuri Oshima: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan; Corresponding author. Department of Respiratory Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-chou, Higashi-Osaka city, Osaka, 579-8026, Japan.
Hiroyuki Matsuura: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Yusuke Sakurai: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Kaho Hirai: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Eriko Tani: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Naoki Yoshimoto: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Kenichi Minami: Department of Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
Fumio Yamasaki: Division of Rehabilitation, Ishikiriseiki Hospital, Osaka, Japan
Mayu Nishime: Division of Nutrition Management, Ishikiriseiki Hospital, Osaka, Japan
Tomonori Hirashima: Department of Thoracic Oncology, Ishikiriseiki Hospital, Osaka, Japan

Journal volume & issue: Vol. 36
p. 101609

Abstract

Read online

Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we started ANA combined with a treatment approach by a multidisciplinary collaboration, including nutritionists and physical therapists. After initiation of ANA, the body weight, appetite, psoas muscle index, and physical functions rapidly improved during chemotherapy. ANA administration combined with a multidisciplinary collaboration approach can be an effective supportive therapy against CCX during chemotherapy.

Published in Respiratory Medicine Case Reports

ISSN: 2213-0071 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: http://www.journals.elsevier.com/respiratory-medicine-case-reports/

About the journal

Abstract

Keywords